FRI0187 A Randomized Crossover Comparison of Injection Site Pain with 40 Mg/0.8 Ml and 40 mg/0.4 ml Formulations of Adalimumab in Patients with Rheumatoid Arthritis
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 2016
has subject area
- 1103 Clinical Sciences (FoR)
- 1107 Immunology (FoR)
- 1117 Public Health and Health Services (FoR)
- Arthritis & Rheumatology (Science Metrix)
published in
- Annals of the Rheumatic Diseases Journal